Healthy Children After Vaccination Clinical Trial
Official title:
Prevenar Post-Licensure Safety Study in Russia: Frequency Of Fever Post Vaccination
This study is planned to monitor the local and/or systemic reactions and compatibility of
PCV-7 with routine vaccines in the Russian National immunization schedule. Consistent with
the observational nature of this protocol, Prevenar will be administered as standard of
care.
The aim of this study is to estimate the incidence of febrile reactions more than 38.0
degrees Celsius, specifically (≥38 to < 39 degrees C; > 39 to < 40 degrees C and > 40
degrees C, and the frequency of other local or systemic reactions following vaccination with
Prevenar (PCV-7) co-administered with other routine childhood vaccines under the conditions
of routine daily use in the Russian Federation.
n/a
Observational Model: Cohort, Time Perspective: Prospective